Intervention not reported
mirtazapine:escitalopram · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
escitalopram:paroxetine · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
escitalopram:sertraline · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
escitalopram:venlafaxine · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Intervention not reported
escitalopram:vilazodone · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
escitalopram:vortioxetine · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Failure to respond at endpoint (6‐12 weeks) · depression
Paroxetine showed no clear difference in failure to respond at endpoint (6‐12 weeks) compared with escitalopram (moderate certainty).
1 finding from 1 review
Failure to respond at 1‐4 weeks · depression
1 finding from 1 review
Failure to respond at 16‐24 weeks · depression
Paroxetine showed no clear difference in failure to respond at 16‐24 weeks compared with escitalopram (moderate certainty).
1 finding from 1 review
Failure to remit at endpoint · depression
Paroxetine showed no clear difference in failure to remit at endpoint compared with escitalopram (low certainty).
1 finding from 1 review
SMD at endpoint · depression
1 finding from 1 review
Failure to complete ‐ any cause ‐ · depression
Paroxetine showed no clear difference in failure to complete ‐ any cause ‐ compared with escitalopram (moderate certainty).
1 finding from 1 review
Participants with at least some Side Effects · depression
Paroxetine showed no clear difference in participants with at least some Side Effects compared with escitalopram (moderate certainty).
1 finding from 1 review
Failure to respond (reduction ≥ 50% on HDRS) · patients with depression
Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with escitalopram (low certainty).
1 finding from 1 review
Endpoint score (HDRS or MADRS) · patients with depression
1 finding from 1 review
Failure to complete ‐ total ‐ · patients with depression
Fluoxetine showed no clear difference in failure to complete ‐ total ‐ compared with escitalopram (moderate certainty).
1 finding from 1 review
Failure to complete ‐ inefficacy ‐ · patients with depression
Fluoxetine showed no clear difference in failure to complete ‐ inefficacy ‐ compared with escitalopram (moderate certainty).
1 finding from 1 review
Failure to complete ‐ side effects ‐ · patients with depression
Fluoxetine showed no clear difference in failure to complete ‐ side effects ‐ compared with escitalopram (moderate certainty).
1 finding from 1 review